Table 1 Year of publication, journal and country of birth or study of patients with anti-NMDAR encephalitis and ovarian teratoma
From: Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases
1A. Year of publication (number of papers) | Number of cases | % |
|---|---|---|
Before/or in 2006 (13) | 16 | 9,2 |
2007 (6) | 14 | 8,1 |
2008 (11) | 18 | 10,4 |
2009 (14) | 17 | 9,8 |
2010 (18) | 21 | 12,1 |
2011 (21) | 27 | 15,6 |
2012 (18) | 27 | 15,6 |
2013 (November 30) (18) | 33 | 19,1 |
TOTAL (119) | 173 | 100 |
1B. Journal of publication | Number of cases | % |
1. Neurology or Psychiatry | 86 | 49,7 |
2. Internal or general medicine | 34 | 19,6 |
3. Other Specialties | 34 | 19,6 |
4. Gynecological, included Oncological Gynecology | 19 | 11,0 |
TOTAL | 173 | 100 |
1C. Country of birth or study | Number of cases | % |
Africa: (Mauritania, France) | 1 | 0,6 |
Asia: (Japan-38; Taiwan-4; Singapore-3, Hong-Kong-2; and 1 in China, India, S-Korea and Lebanon) | 51 | 29,5 |
Australia: (Australia-9; New Zeland-4) | 13 | 7,5 |
Europe: (Spain-7; UK-7; France-6; Germany-5; 3 in Netherlands, Belgium, Italy and Turkey; and 1 in Ireland and Greece) | 39 | 22,5 |
North-America: (USA-47; Canada-4, Mexico-1) | 52 | 30,1 |
Center and South-America: (1 in Brazil, Colombia and Jamaica) | 3 | 1,7 |
Spain (Barcelona) v USA (Pennsylvania) | 14 | 8,1 |
TOTAL | 173 | 100 |